John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$257M |
| 2 |
Boston Scientific
BSX
|
+$228M |
| 3 |
Meta Platforms (Facebook)
META
|
+$225M |
| 4 |
Amazon
AMZN
|
+$220M |
| 5 |
S&P Global
SPGI
|
+$219M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$252M |
| 2 |
PayPal
PYPL
|
+$252M |
| 3 |
Walt Disney
DIS
|
+$217M |
| 4 |
Chevron
CVX
|
+$206M |
| 5 |
Best Buy
BBY
|
+$152M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.83% |
| 2 | Consumer Discretionary | 13.53% |
| 3 | Financials | 9.1% |
| 4 | Healthcare | 9.07% |
| 5 | Consumer Staples | 8.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CTXS
1526
CALL
DELISTED
Citrix Systems Inc
CTXS
| $1.9M | 0.01% |
14,600
+5,900
| +68% | +$750K |
|
|
CNR
1527
DELISTED
Cornerstone Building Brands, Inc.
CNR
| $1.9M | 0.01% |
204,301
-30,452
| -13% | -$270K |
|
|
DVAX
1528
DELISTED
Dynavax Technologies
DVAX
| $1.89M | 0.01% |
425,694
-872,023
| -67% | -$3.95M |
|
1529
PUT
Consolidated Edison
ED
$39.6B
| $1.89M | 0.01% |
26,200
-18,500
| -41% | -$1.44M |
|
1530
PUT
PNC Financial Services
PNC
$97.4B
| $1.89M | 0.01% |
12,700
-11,300
| -47% | -$1.44M |
|
1531
Meritage Homes
MTH
$4.79B
| $1.89M | 0.01% |
+45,600
| New | +$2.16M |
|
1532
Rayonier Advanced Materials
RYAM
$582M
| $1.88M | 0.01% |
288,746
+25,530
| +10% | +$135K |
|
|
CHMA
1533
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $1.88M | 0.01% |
432,964
+54,369
| +14% | +$226K |
|
1534
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.04B
| $1.88M | 0.01% |
36,100
-106,800
| -75% | -$4.88M |
|
1535
GrafTech
EAF
$175M
| $1.87M | 0.01% |
17,578
-21,493
| -55% | -$1.73M |
|
1536
CALL
Elastic
ESTC
$8.36B
| $1.87M | 0.01% |
12,800
-26,200
| -67% | -$3.22M |
|
|
ALPN
1537
DELISTED
Alpine Immune Sciences Inc
ALPN
| $1.87M | 0.01% |
148,443
+67,078
| +82% | +$658K |
|
1538
PUT
Ralph Lauren
RL
$21.6B
| $1.87M | 0.01% |
18,000
+6,000
| +50% | +$503K |
|
1539
CALL
Valero Energy
VLO
$98B
| $1.87M | 0.01% |
33,000
-80,200
| -71% | -$3.93M |
|
|
BKCC
1540
DELISTED
BlackRock Capital Investment Corporation
BKCC
| $1.86M | 0.01% |
693,428
+101,580
| +17% | +$273K |
|
1541
Leslie's
LESL
$5.68M
| $1.86M | 0.01% |
+3,349
| New | +$1.51M |
|
1542
Synopsys
SNPS
$78.3B
| $1.86M | 0.01% |
+7,160
| New | +$1.65M |
|
1543
PUT
Avis
CAR
$5.13B
| $1.85M | 0.01% |
49,700
-113,100
| -69% | -$3.98M |
|
1544
PUT
LGI Homes
LGIH
$1.37B
| $1.85M | 0.01% |
17,500
+7,500
| +75% | +$854K |
|
|
ARR
1545
Armour Residential REIT
ARR
$2.32B
| $1.84M | 0.01% |
34,198
+12,151
| +55% | +$625K |
|
1546
Valmont Industries
VMI
$9.13B
| $1.84M | 0.01% |
+10,540
| New | +$1.64M |
|
|
MACK
1547
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $1.84M | 0.01% |
+267,555
| New | +$1.32M |
|
1548
CALL
Nike
NKE
$58.6B
| $1.84M | 0.01% |
13,000
-4,100
| -24% | -$543K |
|
|
TCS
1549
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
| $1.83M | 0.01% |
+12,821
| New | +$1.87M |
|
1550
PUT
Fiverr
FVRR
$344M
| $1.83M | 0.01% |
9,400
+600
| +7% | +$109K |
|
Similar funds
John Overdeck's Q4 2020 Portfolio in Review
As of Q4 2020, John Overdeck held 3,971 positions worth $34.9B, up 24% from $28.2B the previous quarter. Its ten largest holdings account for 7.4% of the portfolio.
John Overdeck deployed $1.95B of net new capital in Q4 2020, opening 955 new positions and adding to 1,167 existing holdings. Its largest new stake was Boston Scientific: 6,312,819 shares worth $227M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Chevron, an estimated $206M trimmed.
- John Overdeck's largest Q4 2020 buy was Boston Scientific: 6,312,819 shares worth $227M.
- John Overdeck added most to NVIDIA in Q4 2020, an estimated $257M increase.
- John Overdeck's biggest Q4 2020 reduction was Chevron, cutting an estimated $206M.
- John Overdeck fully exited Pfizer in Q4 2020, selling an estimated $252M.
- John Overdeck's ten largest holdings make up 7.4% of its $34.9B portfolio in Q4 2020.
- John Overdeck opened 955 new positions and closed 694 in Q4 2020.
- John Overdeck's portfolio value rose 24% quarter-over-quarter to $34.9B.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.